Plasma sodium and subclinical left atrial enlargement in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 28, Issue 9, 2013, Pages 2319-2328

  Wang, Angela Yee Moon ^a   Lu, Ye ^a   Cheung, Sharon ^a   Chan, Iris Hiu Shuen ^b   Lam, Christopher Wai Kei ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

Chronic kidney disease; Echocardiography; Left atrial enlargement; Plasma sodium

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN; LOOP DIURETIC AGENT; PHOSPHORUS; SODIUM;

ADULT; AGE; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM ENLARGEMENT; HEART LEFT ATRIUM; HEART LEFT ATRIUM VOLUME INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART VOLUME; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE PRESSURE; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

CHRONIC KIDNEY DISEASE; ECHOCARDIOGRAPHY; LEFT ATRIAL ENLARGEMENT; PLASMA SODIUM;

BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SODIUM; ULTRASONOGRAPHY, DOPPLER;

EID: 84884521753     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs588     Document Type: Article

References (44)

1. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315
2. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050-1065
3. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
4. Foley RN, Parfrey PS, Harnett JD et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192
5. London GM, Pannier B, Guerin AP et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001; 12: 2759-2767
6. Wang AY, Wang M, Woo J et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004; 15: 2186-2194
7. Wang AY, Lam CW, Chan IH et al. Sudden cardiac death in endstage renal disease patients: a 5-year prospective analysis. Hypertension 2010; 56: 210-216
8. Zoccali C, Benedetto FA, Tripepi G et al. Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study. J Am Soc Nephrol 2006; 17: 1460-1465
9. Wang AY, Wang M, Lam CW et al. Heart failure in long-term peritoneal dialysis patients: a 4-year prospective analysis. Clin J Am Soc Nephrol 2011; 6: 805-812
10. Hunt SA, Abraham WT, Chin MH et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: e391-479
11. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463
12. Tsang TS, Barnes ME, Gersh BJ et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90: 1284-1289
13. Benjamin EJ, D'Agostino RB, Belanger AJ et al. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995; 92: 835-841
14. Rossi A, Temporelli PL, Quintana M et al. Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure). Eur J Heart Fail 2009; 11: 929-936
15. Meris A, Amigoni M, Uno H et al. Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. Eur Heart J 2009; 30: 56-65
16. Moller JE, Hillis GS, Oh JK et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation 2003; 107: 2207-2212
17. Reed D, Abbott RD, Smucker ML et al. Prediction of outcome after mitral valve replacement in patients with symptomatic chronic mitral regurgitation. The importance of left atrial size. Circulation 1991; 84: 23-34
18. Tripepi G, Benedetto FA, Mallamaci F et al. Left atrial volume in end-stage renal disease: a prospective cohort study. J Hypertens 2006; 24: 1173-1180
19. Tripepi G, Benedetto FA, Mallamaci F et al. Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol 2007; 18: 1316-1322
20. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266
21. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
22. Otterstad JE, Froeland G, St John Sutton M et al. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 1997; 18: 507-513
23. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618
24. Levy D, Savage DD, Garrison RJ et al. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956-960
25. Liao Y, Cooper RS, Durazo-Arvizu R et al. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997; 29: 641-647
26. Oki T, Tabata T, Yamada H et al. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 1997; 79: 921-928
27. He FJ, Markandu ND, Sagnella GA et al. Plasma sodium: ignored and underestimated. Hypertension 2005; 45: 98-102
28. Suckling RJ, He FJ, Markandu ND et al. Dietary salt influences postprandial plasma sodium concentration and systolic blood pressure. Kidney Int 2012; 81: 407-411
29. Strazzullo P, D'Elia L, Kandala NB et al. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009; 339: b4567
30. He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 2011; 378: 380-382
31. Taylor RS, Ashton KE, Moxham T et al. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens 2011; 24: 843-853
32. Kovesdy CP, Lott EH, Lu JL et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 2012; 125: 677-684
33. Lindner G, Funk GC, Schwarz C et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis 2007; 50: 952-957
34. Mohammed AA, van Kimmenade RR, Richards M et al. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study. Circ Heart Fail 2010; 3: 354-361
35. Kovesdy CP. Significance of hypo- and hypernatremia in chronic kidney disease. Nephrol Dial Transplant 2012; 27: 891-898
36. de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int 2004; 66: 2454-2466
37. Spencer KT, Mor-Avi V, Gorcsan J, 3rd et al. Effects of aging on left atrial reservoir, conduit, and booster pump function: a multi-institution acoustic quantification study. Heart 2001; 85: 272-277
38. Greenberg B, Chatterjee K, Parmley WW et al. The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J 1979; 98: 742-751
39. Pritchett AM, Mahoney DW, Jacobsen SJ et al. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 2005; 45: 87-92
40. Nistri S, Olivotto I, Betocchi S et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol 2006; 98: 960-965
41. Patel RK, Jardine AG, Mark PB et al. Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation. Am J Kidney Dis 2010; 55: 1088-1096
42. Kim SJ, Han SH, Park JT et al. Left atrial volume is an independent predictor of mortality in CAPD patients. Nephrol Dial Transplant 2011; 26: 3732-3739
43. Tonelli M, Wiebe N, Culleton B et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-2047
44. Cioffi G, Tarantini L, Frizzi R et al. Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events. J Hypertens 2011; 29: 565-573